Helmholtz-Zentrum Dresden-Rossendorf e.V.
As a member of the Helmholtz Association of German Research Centers, the HZDR employs about 1,400 people. The Center's focus is on interdisciplinary research in the areas energy, health and matter.
At the Institute of Radiopharmaceutical Cancer Research scientists from the fields of physics, chemistry, biology, pharmacy, immunology, medicine and IT develop innovative radiopharmaceuticals and novel tools for functional characterization, improved imaging and personalized treatment of tumors.
As part of the Institute, the Department of Radionuclide Theragnostics invites applications as PostDoc (f/m/d) Functionalization, radiolabeling and characterization of complex protein assemblies.
The position will be available from 1 January 2022. The employment contract is limited to two years.